Phase 01
Screening & Onboarding
Assessment of patients (e.g., in cases of high-risk patients/polypharmacy) and recording of medical history at the point of care.
Tailored precision medicine by combining state-of-the-art bioinformatics and clinical pharmacology.
Precise professional reports for physicians with concrete dosing instructions and safe alternatives.
A regulatory-validated end-to-end process that transforms clinical data into precise therapeutic safety.
Assessment of patients (e.g., in cases of high-risk patients/polypharmacy) and recording of medical history at the point of care.
Execution of genetic, epigenetic, and metabolic tests (e.g., Metabolic Panel) in cooperation with partners.
Linking laboratory data with insurance data (payer data) and real-world evidence (RWE) for a holistic assessment.
Final assessment by clinical pharmacologists and nutrition specialists for risk mitigation.
We solve the most complex challenges of modern pharmacotherapy through clinical validation and innovative bioinformatics.
From the genetic code to the clinical decision: We create digital biological twins for lifelong safe and precise pharmacotherapy.
Bioinformatic simulation of your individual physiology to predict drug reactions.
Mechanistic dose-finding through scientifically sound pharmacokinetic models.
Seamless integration of genetics, epigenetics, laboratory data, and real-world evidence (RWE).
Continuous therapy adaptation by accounting for aging processes and lifestyle.
Directly applicable technical reports for risk minimization in complex polypharmacy.